(Questions) CTCs-derived xenograft development in a triple negative breast cancer case 25 de xuño de 2018
Visto 1
vez
(Questions) CTCs-derived xenograft development in a triple negative breast cancer case
First day focused on the advances related to the diagnosis of diseases.
second day focused on therapies for cancer, neurological or neurodegenerative diseases.
The Symposium brings together more than 200 researchers from Europe and the United States (121 women and 87 men) and comprises a total of 20 papers, ten guest speakers or ten other new researchers, as well as 45 scientific poster sessions.
i18n.one.Series:
II Annual Meeting CINBIO
Thais Pereira Veiga
Oncomet. IDIS, Health Research Institute of Santiago - CIBERONC. Spain
Modera:
Sara Núñez Sánchez
Scientific and Organizing Committee:, CINBIO
Vídeos da mesma serie
Metabolomics and lipidomics to improve diagnosis and nutritional therapy in obesity-related diseases
Conference
25 de xuño de 2018
The use of unnatural MUC1 antigens enable efficient detection of antibodies in patients with cancer
Conference
25 de xuño de 2018
Integration of omic datasets in biomedical prediction models: statistical challenges
Conference
25 de xuño de 2018
CTCs-derived xenograft development in a triple negative breast cancer case
Conference
25 de xuño de 2018
Pharmacological targeting of NMDA receptors and different forms of synaptic plasticity
Conference
26 de xuño de 2018
Synthesis of complex carbohydrates and potential angiotensin II AT2R ligands
Conference
26 de xuño de 2018
Selective melanoma treatment using a targeted chemo-photo thermal therapy
Conference
26 de xuño de 2018
PanDrugs: novel method to prioritize anticancer drug treatments according to individual genomic data
Conference
26 de xuño de 2018
Generation of human induced pluripotent stem cell lines from patients with hand osteoathritis
Conference
26 de xuño de 2018
Tamén che interesan
